Drug
momelotinib
Marketed as OJJAARA.
Generic name
momelotinib
Brand names
OJJAARA
First FDA approval
2023-09-15
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216873 | OJJAARA | 2023-09-15 | GLAXOSMITHKLINE |
Manufacturers
GLAXOSMITHKLINE
Frequently asked questions
When was momelotinib FDA approved?
Earliest FDA approval on record: 2023-09-15.
What brand names are sold as momelotinib?
OJJAARA.
Sources
Appeal a momelotinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com